DCAT Week Cancelled, AGC Biologics to Meet Essentially with Industry Pioneers

As a Contract Improvement and Fabricating Organization (CDMO) centered on collaboration and customer-centricity, these virtual gatherings permit AGC Biologics to fortify connections with industry pioneers. DCAT Week was initially slated to require put from Walk 23- 26 in Modern York City.

During these virtual meetings, AGC Biologics will be sharing information on its globally aligned process development, manufacturing and seamless tech transfers. AGC Biologics will also be highlighting the recent expansion of its plasmid DNA (pDNA) offering. With the demand for pDNA growing rapidly, AGC Biologics is leveraging 25 years of experience and comprehensive in-house analytics development to ensure short and dependable timelines.

“In these unprecedented times, AGC Biologics is committed to maintaining strong customer partnerships. We are looking forward to connecting with industry professionals from across the globe,” says AGC Biologics CEO Patricio Massera. “AGC Biologics is pleased to have the opportunity to meet with leading industry experts and share information about our latest innovations.”